Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
16 19 Search
2024
Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entry
Frontiers in Immunology
2024
Up-regulated DSG2 promotes tumor growth and reduces immune infiltration in cervical cancer
Pathology - Research and Practice
2024
DSG2 and c-MYC Interact to Regulate the Expression of ADAM17 and Promote the Development of Cervical Cancer
Cancer Management and Research
2023
Desmoglein-2 as a cancer modulator: friend or foe?
Frontiers in Oncology
2023
Desmoglein-2 and COVID-19 complications: insights into its role as a biomarker, pathogenesis and clinical implications
Journal of General Virology
2022
The prognostic and clinicopathological significance of desmoglein 2 in human cancers: a systematic review and meta-analysis
PeerJ
2022
Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma
Journal of Healthcare Engineering
2022
Role of Fiber Shaft Length in Tumor Targeting with Ad5/3 Vectors
Genes
2022
Prognostic utility of the ovarian cancer secretome: a systematic investigation
Archives of Gynecology and Obstetrics
2022
Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
Bioscience Reports
2021
Further discussion on the association between desmoglein 2 and tumor size of non-small cell lung cancer
Journal of Cancer Research and Clinical Oncology
2021
Desmosomes as Signaling Hubs in the Regulation of Cell Behavior
Frontiers in Cell and Developmental Biology
2020
Co-Expression of Coxsackievirus/Adenovirus Receptors and Desmoglein 2 in Lung Adenocarcinoma: A Comprehensive Analysis of Bioinformatics and Tissue Microarrays
Journal of Clinical Medicine
2020
Genetic Factors Involved in Cardiomyopathies and in Cancer
Journal of Clinical Medicine
2020
Desmoglein-2 as a prognostic and biomarker in ovarian cancer
Cancer Biology & Therapy
Additional cited-by details will be shown when available from Crossref